FUJIFILM Biosciences Name Change Takes Effect As Life Sciences Group Restructuring Moves Into Execution

06 January 2026 | Tuesday | News

Formerly FUJIFILM Irvine Scientific, the company officially adopts the FUJIFILM Biosciences identity from January 1 2026, signalling an expanded end to end life sciences portfolio built on 55 years of cell culture innovation.

  • Rebrand announced in June as part of Fujifilm Life Sciences Group restructuring becomes official
  • FUJIFILM Irvine Scientific becomes FUJIFILM Biosciences, providing a full spectrum of life sciences solutions built from a 55-year history as a cell culture pioneer.

 

FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the life science market,  announced the Company has officially changed its legal name from FUJIFILM Irvine Scientific, Inc., to FUJIFILM Biosciences Inc., effective January 1, 2026. The FUJIFILM Biosciences’ name builds upon the Company’s roots as a pioneer in the cell culture media industry that through a core focus on people, innovation, and quality now serves a much broader life science community and customers.

 

FUJIFILM Biosciences continues to be dedicated to its customers with a focus on empowering scientists and researchers at every stage of discovery, development, and commercialization. By offering a comprehensive portfolio of products and services in cell culture media, feeds, specialty chemicals and reagents, single-use technologies, and human-induced pluripotent stem cell capabilities, the Company supports and helps accelerate the development of life-changing treatments that can improve patient outcomes worldwide.

 

All of us at FUJIFILM Biosciences take immense pride in being a people-focused company that empowers our colleagues to create an exceptional customer experience,” said Brandon Pence, president and chief operating officer, FUJIFILM Biosciences. “We utilize our 55-year legacy of deep industry knowledge to collaboratively develop innovative solutions and technologies that are supplied from our global network of manufacturing facilities. With this approach and our ongoing investments, we look ahead to a strong future with our employees, customers, and partners around the world.

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close